PMI - צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים Picard Group

The YoY sales growth over the last four quarters reflects market expectations for Picard Medical Inc (PMI). 41.10 determines the latest valuation metric, based on partnerships with clinics to implement SynCardia systems. Strong physician confidence in these unique cardiac devices supports the brand. However, slow EU regulatory approvals and a lack of liquidity create significant financial risks.
פילוחי נתונים אנליטיים מרוכזים עבור Picard Medical (PMI)

This indicator calculates the daily year-over-year revenue growth rate, isolating the steady organic trend from one-off market spikes to objectively assess business scaling. By analyzing the annual growth rate of sales revenue (rolling period), an investor can discern the effectiveness of the Picard Medical Inc. (PMI) strategy, where the retention of scarce biomedical engineers and quality experts provides a stable technological foundation for expansion.